Eleven drug companies settled litigation that charged they knowingly inflated average wholesale price for drugs in the Medicare Part B program.
Eleven pharmaceutical companies have agreed to pay $125 million to settle a case in which they allegedly inflated the average wholesale prices (AWP) on certain prescription drugs in the Medicare Part B program. In separate FirstdataBank and McKesson charging inflation of AWP. Any Medicare Part B beneficiary who was charged a copay from 1991 through 2004 may be eligible for reimbursement under the settlement. Abbott, Amgen, Aventis, Baxter, Bayer, Dey, Fujisawa, Pharmacia & Upjohn, Teva, Watson Pharmaceuticals, and ZLB Behring were all parties to the settlement.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.